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Phosphorus-31 nuclear magnetic resonance spectroscopy 
can determine the status of high energy phosphates in vivo. 
However, its application to human cardiac studies requires 
precise spatial localization without significant contamina-
tion from other tissues. Using image-selected in-vivo spec-
troscopy (ISIS), a technique that allows three-dimensional 
localization of the volume of interest, 12 subjects were 
studied to determine the feasibility and reproducibility of 
phosphorus-31 spectroscopy of the human heart. Nuclear 
magnetic resonance imaging was performed using a com-
mercial 1.5 tesla system to define the volume of interest. 
Phosphorus-31 spectra were obtained from the septum 
and anteroapical region of the left ventricle in 10 studies. 
Phosphorus-31 nuclear magnetic resonance (NMR) spectros-
copy is a noninvasive technique that can measure high 
energy phosphates in living systems (1). The heart uses 
adenosine triphosphate (ATP) to provide energy for muscle 
contraction and ion transport, whereas phosphocreatine 
serves as a metabolic reserve (2). Abnormalities of high 
energy phosphates are characteristic of myocardial ischemia 
and hypoxia (3) and thus measurement of these compounds 
may give insight into these processes. In most studies (4), 
high energy phosphates have been measured using freeze-
From the *Magnetic Resonance Unit and tCardiology Section, Veterans 
Administration Medical Center; §Department of Medicine, University of 
California, San Francisco, California and the ~University of Palermo, Pa-
lermo, Italy. This work was supported by the Veterans Administration 
Medical Research Service and National Institutes of Health Grants K08 
HL02 131-0 1 , R01 AM 33923-04 and F32 AM07770-01 and Philips Medical 
Systems, Best, The Netherlands and Shelton, Connecticut. Dr. Valenza is a 
Fellow of Assessorato Sanita' Regione Sicilia Progetto Finializzato Sanita' N 
318/M. 
Manuscript received May 9, 1988; revised manuscript received July 12, 
1988, accepted July 26, 1988. 
Address for reprints: Saul Schaefer, MD, Veterans Administration Med-
ical Center, Magnetic Resonance Unit (110), 4150 Clement Street, San 
Francisco, California 94121. 
© 1988 by the American College of Cardiology 
Relative peak heights and areas were determined for high 
energy phosphates. The mean phosphocreatine to adeno-
sine triphosphate ratio was 1.33 ± 0.19 by height analysis 
and 1.23 ± 0.27 by area analysis. Duplicate measurements 
in four subjects showed a reproducibility of :s10% in three 
of the subjects. All spectra showed significant signal con-
tribution from the 2,3 diphosphoglycerate in chamber red 
cells without evidence of skeletal muscle contamination. 
These results demonstrate the feasibility of image-
guided phosphorus-31 spectroscopy for human cardiac 
studies and indicate the potential of this technique to study 
metabolic disturbances in human myocardial disease. 
(J Am Coli CardioI1988;I2:1449-55) 
clamp techniques that required destruction of tissue and 
usually precluded repetitive measurements in the same ex-
perimental system. Because of its nondestructive nature and 
ability to measure mUltiple compounds simultaneously, 
phosphorus-31 NMR spectroscopy has been increasingly 
employed to obtain serial measurements of high energy 
phosphates in experimental preparations, including perfused 
hearts (5-7) and open and closed chest animals (8-16). 
The application of phosphorus-31 spectroscopy to studies 
of the human heart is complicated by the need to obtain 
spectra that are localized to the heart without contamination 
by overlying tissues. Several investigators (17,18) have 
obtained human cardiac spectra, but in these techniques the 
lateral dimensions of the selected volume were defined by 
the sensitivity profile of the surface coil. Thus, possible 
contamination by noncardiac tissues, as well as imprecision 
in defining the volume of interest, limits the clinical potential 
of these techniques. If phosphorus-31 spectroscopy is to 
become an important clinical or investigational tool, it will 
be necessary to acquire spectra from predetermined and 
clearly defined myocardial regions. 
Image-selected in-vivo spectroscopy (ISIS) is a localiza-
0735-1097/88/$3.50 
IE HUMAN HEART 
e-dimensional 
tandard NMR 
tation of ISIS 
0), there now 
ic regions for 
:fore, the goal 
)horus metab-
a localization 
ined three-di-
y active men, 
tesla nuclear 
magnetic resonance (NMR) imaging and spectroscopy sys-
tem (Philips Medical Systems). Each subject was free of 
known cardiac disease as determined by history and physical 
examination. After informed consent was obtained, the point 
of maximal cardiac impulse was determined by palpation. 
The subject was placed in the bore of the magnet in the left 
lateral decubitus position so that the point of maximal 
cardiac impulse was directly over a 9 cm diameter single t~rn 
receiving and transmitting surface coil. Because the selected 
volume must be within one diameter of the coil, this coil size 
was chosen to provide a sufficient sensitive volume to 
encompass the volume of interest while maintaining flexi-
bility in patient positioning. A small vial containing hexa-
methylphosphorous triamide was fixed near the center of the 
surface coil to provide a spatial reference for surface coil in 
the image and a pulse length reference for spectroscopy. 
Transaxial NMR imaging was then performed using an 
electrocardiographically (ECG) gated multislice spin-echo 
sequence with an echo time of 30 ms and a slice thickness of 
10 mm. 
For selection of the volume of interest, an image was 
chosen in a plane through the middle of the left ventricle that 
also demonstrated the position of the surface coil reference 
(Fig. 1). The X and Y axis coordinates of the volume were 
determined from this image, whereas the coordinates in the 
Z axis (along the bore of the magnet) were selected from the 
set of transaxial images. The volume was chosen to satisfy 
the following requirements: 1) minimal dimension along any 
axis of 25 mm, 2) maximal dimension along any axis of 90 
mm, and 3) no volume element located laterally beyond the 
edge of the surface coil. The volume was also selected to 
include as much left ventricular myocardium as possible 
without contamination of the volume by skeletal muscle. 
This last point is especially important because the ratio of 
phosphocreatine to adenosine triphosphate (A TP) of skeletal 
muscle is much greater than that of cardiac muscle (21), and 
any contribution by skeletal muscle to the signal will falsely 
elevate this ratio. 
After image acquisition and selection of the volume of 
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Figure 1. A transaxial nuclear magnetic resonance image obtained 
using a multi slice spin-echo technique (repetition time = 1,840 ms, 
echo time = 30 ms). The hexamethylphosphorous triamide (HMPT) 
reference is above the center of the coil. The rectangular image-
selected in-vivo spectroscopy (ISIS) volume of interest is outlined in 
two dimensions and incorporates the septum and anteroapical 
region of the left ventricle (LV). CW = chest wall; RV = right 
ventricle. 
interest, the surface coil was tuned and matched to the 
phosphorus frequency. A Gordon-Timms arrangement (22) 
was used to tune to the proton frequency and manual 
shimming was performed in the standard manner. The 90° 
pulse for the hexamethylphosphorous triamide reference 
was determined and the optimal 90° pulse for the center of 
the volume of interest was calculated from computer simu-
lations of the radiofrequency field of the surface coil (23). An 
ECG-gated experiment with a repetition time equal to either 
one or two RR intervals, depending on the subject's heart 
rate, was used to acquire the phosphorus spectra. The 
acquisitions (l,024 to 2,048) were summed for each experi-
ment. Four subjects were studied on two separate occasions 
to determine the reproducibility of the measurements. 
The ISIS experiment. The localization technique of ISIS 
was chosen for these studies because standard NMR images 
could be used to preselect a volume of interest located within 
one diameter of the surface coil. In addition, selection of the 
volume of interest was not strictly dependent on the position 
of the surface coil. In these experiments, the standard ISIS 
technique (see Appendix) was modified to reduce contami-
nation from tissue outside the vplume of interest (24). 
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Figure 2. Schematic diagram of the image-selected in-vivo spec-
troscopy (ISIS) experiment shown in Figure I. Computer-generated 
isocontour sensitivity lines are superimposed on the selected rec-
tangular volume of interest. The central isocontour line denotes 
100% sensitivity of detection of the signal, whereas the surrounding 
contour lines represent regions of 75, 50 and 25% sensitivity. The 
majority of the signal is derived from the anterior portion of the ISIS 
volume overlying the left ventricle (LV), but the boundaries of the 
chosen volume of interest are exceeded. Abbreviations as in Fig-
urel. 
To accurately define the ISIS volume for our experimen-
tal conditions, modeling of the ISIS experiment was per-
formed using an IBM PC/AT computer (23). Although the 
chosen volume for each study was rectilinear, the true 
volume from which the signal was obtained is more accu-
rately depicted by signal intensity isocontour lines (Fig. 2). 
In this two-dimensional representation of the same experi-
ment seen in Figure I, the isocontour lines were calculated 
for regions of 100, 75, 50 and 25% sensitivity. The volume 
from which the signal was detected began anterior to the 
chosen volume and extended into the cardiac chamber. 
Furthermore, the contribution to the total signal was 
weighted to the nuclei in the anterior portion of the volume. 
This spatial distribution could aid cardiac studies through its 
greater sensitivity to nuclei in the region of the left ventric-
ular apex while having lower sensitivity to more distant 
nuclei in the chamber blood. 
This computer modeling also provided information to aid 
selection of the volume of interest to avoid contamination 
from extracardiac structures. For our studies, the volume 
was chosen to be sufficiently far from the chest wall to avoid 
significant contribution from skeletal muscle. Thus, unlike 
techniques that depend on the radiofrequency field profiles 
of the surface coil to determine the lateral margins of the 
signal volume (18), the volume in these experiments could be 
defined in three dimensions for any given set of conditions. 
Image analysis. The relative contributions of myocar-
dium, chamber blood and noncardiac structures to the peak 
intensities of the spectra are a complex function of both the 
number and the position of the nuclei of interest in the 
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volume of interest. Computation of the relative mass of these 
structures to the total selected volume can aid in understand-
ing these experiments. To estimate the proportion of the 
ISIS volume occupied by cardiac muscle in each study, 
NMR images originally chosen for selection of the volume 
were photographed and enlarged. The cardiac muscle and 
ventricular chamber within the planar region chosen from 
the images were determined by planimetry for each experi-
ment. The myocardial and chamber areas were calculated 
and expressed as a percent of the ISIS area. These ratios 
were used as estimates of the actual proportion of the ISIS 
volume occupied by both ventricular myocardium and cham-
ber blood and were expressed as percent areas. 
Spectral analysis. Spectra from the subjects were ana-
lyzed using the NMR I software package obtained from 
Syracuse University. Each free induction decay was proc-
essed using a convolution difference of 200 Hz and an 
exponential multiplication of 10 Hz. Baseline correction was 
performed using fifth order polynomial routines. Peaks were 
assigned to phosphomonoesters, phosphocreatine, phospho-
diesters and the three phosphates of ATP based on known 
chemical shifts. Gaussian line fits were used for peak height 
and area analyses because this model produced smaller 
variances from the actual spectra than did Lorentzian line 
fits. Peak heights and areas were determined for all the 
phosphate resonances, and the ratios of phosphocreatine to 
gamma-ATP height and area were calculated for each sub-
ject. The beta-ATP resonance was not used in these calcu-
lations because the iSIS experiment has off-resonance ef-
fects that alter the intensity of peaks distant from the carrier 
frequency (25). The signal to noise ratio for each spectrum 
was calculated by computer with use of the phosphocreatine 
resonance. All results were expressed as mean values ± SD. 
Results 
A representative spectrum from a normal subject is 
shown in Figure 3. Two experiments with selected volumes 
under 50 cc did not produce spectra with adequate signal to 
noise ratios for analysis; thus the data presented are for 10 
patients. Spectra were obtained from these subjects with a 
mean data acquisition time of 35 ± 13 min and a mean 
repetition time of 1,550 ± 265 ms. The mean selected ISIS 
volume was 78 ± 19 cc. On average, cardiac muscle consti-
tuted approximately 57% of the volume, chamber blood 
occupied approximately 28% and lung contributed the re-
mainder. Line widths for proton spectra acquired for shim-
ming averaged 50 Hz. 
Spectral analysis. Peaks of phosphocreatine and the three 
phosphates of ATP were clearly resolved in all analyzed 
spectra. The signal to noise ratio for phosphocreatine in 
these spectra was 6.9 ± 1.9. Inorganic phosphate was not 
resolved in any spectra because of overlap with the blood 2,3 
diphosphoglycerate resonance. The ratio of the peak heights 
1452 SCHAEFER ET AL. 
PHOSPHORUS-31 SPECTROSCOPY OF THE HUMAN HEART 
PCr 
PME 
a 
1""""'1"""'"1'''''''''1'''''''''1'''''''''1'''''""1""""'1""""'1""""'1""""'1 
tlll.OO 10.00 5.00 0.00 -1.00 -10.00 -11.00 -RO.De -21.00 -30.00 
PPM 
Figure 3. A representative phosphorus-31 human cardiac spec-
trum. The peaks identified are those of the alpha, beta and gamma 
phosphates of adenosine triphosphate, phosphocreatine (PCr) and 
phosphomonoesters (PME). A phosphodiester peak is not clearly 
seen. PPM = parts per million. 
of phosphocreatine to ATP was 1.33 ± 0.19 for the 10 
subjects, whereas the ratio of peak areas was 1.23 ± 0.27 
(Table 1), Phosphodiester peaks were also present in all 
spectra, but their magnitude did not relate to either absolute 
or relative measures of phosphocreatine or ATP. In addition, 
their overlap with the phosphocreatine resonance made 
accurate area measurement of phosphocreatine difficult. 
ReprodUcibility. Analysis of the four repeat studies dem-
onstrated excellent reproducibility (:510%) of the phospho-
creatine to ATP height ratios for three of the four subjects 
(Table 1), In one subject (Subject 7) this ratio was 30% 
higher on the repeat study using a smaller volume (65 versus 
95 cc) with a lower signal to noise ratio (5.6 versus 10.6), 
Area analyses of the phosphocreatine to ATP ratios demon-
strated poor reproducibility due to the relatively large errors 
Table 1. Phosphocreatine/Adenosine Triphosphate (PCr/ ATP) 
Ratios for Spectra on 10 Human Subjects 
PCr/ATP Ratios 
Subject Height Area 
1.61 (1.47) 1.50 (0.94) 
2 1.20 1.16 
1.37 (1.51) 0.93 (1.57) 
4 1.49 1.30 
5 1.13 1.43 
6 1.57 (1.55) 1.71 (1.56) 
7 1.22 (1.75) 0.79 (1.56) 
8 1.26 1.29 
9 1.41 1.20 
\0 1.01 0.97 
Mean 1.33 1.23 
SD 0.19 0.27 
Values in parentheses are for repeat studies. 
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in peak fitting with the available signal to noise ratios in these 
spectra. 
Discussion 
This study has demonstrated the feasibility of performing 
image-selected in-vivo spectroscopy on the human heart. 
Our approach differs significantly from previous studies of 
the human heart in that it performs three-dimensional local-
ization of the volume of interest using conventional nuclear 
magnetic resonance (NMR) imaging gradients. This enables 
acquisition of spectra that exclude contributions from skel-
etal muscle and are specifically localized to the anteroapical 
region of the left ventricle. 
Previous localization techniques. Previous studies of hu-
man heart have relied on two-dimensional magnetic field 
gradients or inhomogeneity of the surface coil radiofre-
quency field, or both, to define the region of interest in the 
NMR experiment. Bottomley (17) used depth resolved sur-
face coil spectroscopy (DRESS) to obtain human cardiac 
phosphorus-31 spectra. This technique defined disks of 
tissue parallel to the plane of the coil with use of selective 
slice excitation in the presence of a magnetic field gradient. 
The lateral extent of each disk was determined by the 
sensitive volume of the surface coil. Thus, the volume of 
interest was limited to planes parallel to the surface coil, and 
contribution to the spectra by tissue outside the region of 
interest (such as the right ventricle or skeletal muscle) may 
have been difficult to avoid. 
Studies by Blackledge et al. (18) used the rotating frame 
experiment, which relied solely on the inhomogeneity of the 
surface coil radiofrequency field to define volumes of inter-
est. The regions so defined could be roughly approximated 
by concave disks parallel to surface coil. The volumes in 
these studies were not defined by imaging, but rather were 
inferred from changes in the characteristics of the spectra as 
disks were sequentially obtained at different depths from the 
chest wall. Thus, contributions of various tissues to each 
volume were not well defined. Furthermore, this technique 
may have obtained information predominantly from the 
more anterior right ventricle rather than the left. 
In contrast, the ISIS experiment may be coupled to a 
cardiac image obtained by proton NMR imaging that prede-
fines a volume of interest for phosphorus-31 spectroscopy. 
As our studies demonstrate, spectra can be acquired from 
well defined regions comprised primarily of left ventricular 
myocardium. 
Considerations in volume selection. Selection of the vol-
ume of interest influences the resultant spectra in several 
ways. First, the selected volume must be of adequate size, 
both in absolute terms and in relation to the sensitive volume 
of the surface coil, to provide reasonable sensitivity and, 
therefore, signal to noise ratios. In our system, a volume of 
::::::50 cc (roughly 3 x 4 x 4 cIJ1) 'is required to obtain an 
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adequate spectrum. Second, the configuration and relation 
of the volume of interest to the surface coil determines the 
shape of the volume from which the signal is obtained. Thus, 
the relative contributions of myocardium and blood to the 
signal depend on the position and dimensions of the selected 
volume. The contribution of blood to the ATP resonances 
can be approximated because prior studies (10,26,27) on 
blood have shown ratios for 2,3 diphosphoglycerate to ATP 
of 10: I or greater. With use of the image analysis for 
chamber blood contribution, the chamber blood in the ISIS 
volume should have contributed to ::;5% of the magnitude of 
the A TP signal in the spectra. 
In addition to the small contribution to the ATP reso-
nance, the signal from blood results in large peaks that 
overlap the inorganic phosphate signal. Although not signif-
icant for the spectral analyses in this experiment, this 
overlap may complicate future experiments that require 
accurate quantification of inorganic phosphate or measure-
ment of pH using its chemical shift. 
Other characteristics of the ISIS experiment are germane 
to our results. One of these is the spatial shift of the true ISIS 
volume for each phosphorus nucleus having a different 
chemical shift (sometimes termed the spatial off-resonance 
effect). This effect resulted in a volume shift of the beta-ATP 
resonance approximately 8 mm away from the coil, thereby 
diminishing its intensity and precluding use of the beta-ATP 
peak for analysis. The ISIS experiment is also sensitive to 
motion artifact. Spatial localization is achieved by proper 
addition of eight consecutively acquired signals from inside 
the selected volume with cancellation of signals from outside 
the volume. Because these signals are acquired over a 10 to 
15 s period, motion of the subject can result in incomplete 
cancellation of signals from the region outside the volume of 
interest. The effect of this would be to contaminate the 
spectrum with unwanted signals that could falsely alter 
resonance intensities and increase the noise. Although the 
contribution of motion in these experiments was minimized 
by EeG triggering, its magnitude is unknown and it is a 
potential factor in determining the signal to noise ratio for 
any experiment. 
Previous studies. Our results are similar to those of 
previous phosphorus-31 spectroscopy studies of normal sub-
jects. Bottomley (17) obtained a phosphocreatine to ATP 
ratio of 1.3 in normal subjects and Blackledge et al. (18) 
found a phosphocreatine to ATP ratio of 1.55 ± 0.20 in six 
subjects. 
Preliminary studies of patients with cardiac disease have 
also been performed using phosphorus-31 spectroscopy. In a 
nonlocalized surface coil experiment on an 8 month old child 
with massive cardiomegaly, Whitman et al. (28) found both 
abnormal phosphocreatine/ATP and phosphocreatine/inor-
ganic phosphate values that improve with metabolic therapy. 
Bottomley et al. (29) used the DRESS technique to examine 
four patients 5 to 9 days after myocardial infarction and 
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Table 2. Phosphocreatine/Adenosine Triphosphate (PCr/ATP) 
Ratios in Previous In-Vivo Studies 
Rep 
Reference Model Method Time (s) n PCr/ATP 
Grove et al. (8) Rat sc 10 1.64 ± 0.07* 
Koretsky et al. (9) Rat cc 10 6 1.3 ± 0.15t 
Bittl et al. (10) Rat sc 12.5 10 2.02 + 0.33t 
Canby et al. (II) Rat sc 1.4 8 2.2 ± 0.20t 
Tamatsu et al. (12) Guinea pig sc I 7 1.26 + 0.13* 
Malloy et al. (13) Rabbit sc 8 21 2.20 ± 0.09* 
Balaban et al. (14) Dog cc 2 7 1.46 ± 0.07* 
Guth et al. (15) Dog sc 2.2 8 2.16 ± 0.39t 
Bottomley et al. (16) Dog sc, DR 1 7 1.5 ± 0.3t 
Whitman et al. (28) Child sc 2 2.0 
Bottomley (17) Adult SC, DR 1.3 
Blackledge et al. (18) Adult sc, RF 3.5 6 1.55 ± 0.20t 
Present study Adult sc, ISIS 1.55 10 1.33 ± 0.19t 
*Standard error; tstandard deviation. cc = catheter coil; DR = DRESS 
(17); Rep = repetition; RF = rotating frame; sc = surface coil. 
noted elevated inorganic phosphate levels in some spectra, 
although no significant abnormalities in the phosphocreatine/ 
ATP ratio were seen. Rajagopalan et al. (30) studied seven 
patients with hypertrophic cardiomyopathy using the rotat-
ing frame technique. Five patients had normal metabolic 
profiles, but one patient studied with right ventricular hyper-
trophy and congestive heart failure showed an abnormal 
phosphocreatine/ATP ratio of 0.9 ± 0.2. Two patients had 
abnormal peaks in the phosphomonoester and phospho-
diester regions of the spectra. Increases in the phospho-
diester peaks have also been noted in volume-localized 
spectra obtained from three patients with cardiac hypertro-
phy (31), and may indicate abnormalities of phospholipids in 
these patients (32). Although these studies demonstrate that 
measurement of phosphorus metabolites in humans may 
provide insight into abnormal cardiac metabolic processes, 
the diagnostic utility of phosphorus-31 spectroscopy will 
depend on demonstration of accurate tissue localization as 
well as specificity of these findings for disease processes. 
In-vivo animal studies have, in general, found phospho-
creatine/ A TP ratios similar to those measured in humans. 
The values of this ratio have ranged from 1.26 to 2.2 with use 
of repetition times varying from I to 12.5 s (Table 2). These 
measurements approximate those obtained using freeze-
clamp techniques (33,34). 
Limitations of study. In addition to the localization con-
straints of the ISIS experiment noted earlier, this study has 
several limitations. First, the subjects used in our experi-
ments were all male and in a narrow age range, so our values 
cannot be generalized to more heterogeneous popUlations. 
Second, as noted, saturation effects can alter the measure-
ment of different metabolites if the repetition time of the 
experiment is not long compared with the time required for 
the nuclei to relax to their original states (expressed as the 
1454 SCHAEFER ET AL. 
PHOSPHORUS-31 SPECTROSCOPY OF THE HUMAN HEART 
longitudinal relaxation time, T1). In animal studies (35), the 
reported T 1 values for phosphocreatine are longer than those 
for ATP in cardiac muscle. If this is also true for the human 
heart, phosphocreatine would be more saturated and the 
phosphocreatine to ATP ratio might be systematically un-
derestimated. However, previous studies have not compen-
sated for saturation effects and, in one case (17), increasing 
the repetition period from 1 to 8 s did not appreciably change 
the phosphocreatine/ATP ratio. 
Finally, the signal to noise ratio in the spectra did not 
allow accurate fits for area determinations. Compared with 
peak height analysis, area measurements resulted in larger 
errors in intensity measurements and poorer reproducibility 
between studies in peak area determinations. Use of height, 
rather than area, analysis can make comparisons of metab-
olite levels between studies difficult because of changes in 
line widths of different metabolites. This problem can be 
alleviated by improving the sensitivity of the experiment 
through the use of longer acquisition times, larger volumes 
of interest or higher field strengths. In addition, improved 
data processing to deal with broad components in the 
phosphocreatine region may improve the accuracy of area 
measurements. 
Conclusions. This study has demonstrated that three-di-
mensional image guided in-vivo spectroscopy can be suc-
cessfully performed in humans. Abnormalities in the levels 
of high energy phosphates have been measured with use of 
phosphorus-31 spectroscopy in animal models of cardiac 
allograft rejection (11) and anthracycline cardiotoxicity (36) 
and in the human heart in a small number of patients with 
congenital cardiomyopathies (28,30) or ischemic heart dis-
ease (29). Thus, noninvasive measurement of high energy 
phosphates may aid in the diagnosis and treatment of these 
disorders. The ability to select anatomic regions through 
nuclear magnetic resonance imaging should improve the 
capabilities of phosphorus-31 spectroscopy for the study of 
normal and pathologic processes in the human heart. 
Appendix 
Image-Selected In-Vivo Spectroscopy (ISIS). 
ISIS is a localization technique, originally described by Ordidge 
et al. (19), that allows the selection of a rectilinear volume of interest 
from proton nuclear magnetic resonance images. Unlike techniques 
that rely on the gradients of the surface coil radiofrequency field, 
localization in ISIS is accomplished by frequency selective inver-
sion pulses applied in the presence of the same magnetic field 
gradients used in imaging (Fig. 4). Each inversion pulse inverts a 
selected plane of magnetization with the rectilinear volume of 
interest defined by the intersection of the three orthogonal planes. 
This process is followed by a delayed observation pulse that allows 
for the decay of eddy currents. A sequence of eight different 
acquisitions with different combinations of inversion pulses are 
added to obtain the final spectrum. Thus, signals from within the 
RF pulse and 
signal 
acquisition 
sequence 
Gradient 
sequence 
x y z 
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Figure 4. A representation of the image-selected in vivo spectros-
copy (ISIS) experiment. The volume of interest is selected during a 
preparation period with orthogonal gradients (G) and selective 1800 
radiofrequency (RF) pUlses. The signal is acquired after a magnet 
stabilization delay period to allow time for decay of eddy currents. 
Eight different combinations of pulses are used and the resulting 
acquisitions are summed using proper signs. Adapted, with permis-
sion, from Ref. 19. 
volume of interest are summed with correct signs, whereas signals 
from outside this volume, but still within the sensitive volume of the 
surface coil, are summed with opposite signs and are thus cancelled. 
In the current experiments, the inversion pulses were frequency-
modulated pulses similar to the pulse previously described by Silver 
et al. (37) used to compensate for the inhomogeneity of th.e surface 
coil magnetic field (25). In addition, this technique has been modified 
in our laboratory by the addition of a 900 composite pulse sequence 
(24) immediately after signal acquisition, which reduces contamina-
tion from regions outside the volume of interest. 
The Philips spectroscopy package was developed by Jan den Hollander, PhD 
and Peter Luyten, PhD. The assistance of James Buchanan is gratefully 
acknowledged. 
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